SCHEMBL4640729

SCHEMBL4640729

CCC(OC(=O)c1cc(C)c(Cl)cc1C(=O)OC(CC)C(C)(C)C)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 1/20 0.36
MAPT P10636 3/20 0.33
GAA P10253 2/20 0.33
LMNA P02545 1/20 0.33
HTR1E P28566 1/20 0.33
S1PR3 Q99500 1/20 0.33
CA1 P00915 5/20 0.32
CA2 P00918 5/20 0.32
CA12 O43570 4/20 0.32
CA9 Q16790 4/20 0.32
GRM1 Q13255 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
BAZ2B Q9UIF8 1/20 0.32
BAZ2A Q9UIF9 1/20 0.32
HPGD P15428 1/20 0.32
AGTR1 P30556 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640895 0.95 UTS2R (0.34) UTS2RMAPTGAALMNAHTR1E
SCHEMBL4640736 0.95 UTS2R (0.34) UTS2RMAPTGAALMNAHTR1E
SCHEMBL4639998 0.91 GRM1 (0.36) UTS2RMAPTGRM1MEN1KMT2A
SCHEMBL4640612 0.86 UTS2R (0.36) UTS2RLMNACA2GRM1HPGD
SCHEMBL4640058 0.85 MEN1 (0.38) HPGDMEN1KMT2ATSHR
SCHEMBL4640671 0.85 GRIN2D (0.32) UTS2RHPGDMEN1KMT2A
SCHEMBL4640001 0.85 SMN1; SMN2 (0.36) UTS2RGAAGRM1HPGDMEN1
SCHEMBL4639974 0.84 GRM1 (0.33) UTS2RGRM1MEN1KMT2ASMN1; SMN2
SCHEMBL4641025 0.82 L3MBTL1 (0.36) UTS2RLMNAGRM1HPGDMEN1
SCHEMBL4640615 0.82 ALDH1A1 (0.38) UTS2RHPGDMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX UTS2R 2908/4885MAPT 814/4885GAA 4147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.